Skip to main content
logo
Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
2.050
-0.020 (-0.97%)
Aug 15, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Pharmaceutical
332.31M
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Growth
185.66%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
United States
332.31M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
185.66%
Log In
Log In
Log In
Log In
Upgrade